Oaktop Capital Management II’s Anika Therapeutics ANIK Stock Holding History

Oaktop Capital Management II’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,500	Closed	-$566K	–	17
2020 Q4	$566K	Hold	12,500	–	–	0.1%	18
2020 Q3	$442K	Hold	12,500	–	–	0.1%	19
2020 Q2	$472K	Hold	12,500	–	–	0.11%	20
2020 Q1	$361K	Hold	12,500	–	–	0.11%	19
2019 Q4	$648K	Hold	12,500	–	–	0.17%	17
2019 Q3	$686K	Hold	12,500	–	–	0.14%	15
2019 Q2	$508K	Hold	12,500	–	–	0.11%	17
2019 Q1	$378K	Hold	12,500	–	–	0.08%	18
2018 Q4	$420K	Hold	12,500	–	–	0.12%	16
2018 Q3	$527K	Hold	12,500	–	–	0.12%	18
2018 Q2	$400K	Hold	12,500	–	–	0.09%	18
2018 Q1	$622K	Hold	12,500	–	–	0.13%	18
2017 Q4	$674K	Hold	12,500	–	–	0.14%	19
2017 Q3	$725K	Hold	12,500	–	–	0.12%	19
2017 Q2	$617K	Hold	12,500	–	–	0.11%	20
2017 Q1	$543K	Hold	12,500	–	–	0.11%	20
2016 Q4	$612K	Hold	12,500	–	–	0.13%	18
2016 Q3	$598K	Hold	12,500	–	–	0.14%	18
2016 Q2	$671K	Hold	12,500	–	–	0.16%	18
2016 Q1	$559K	Hold	12,500	–	–	0.14%	17
2015 Q4	$477K	Hold	12,500	–	–	0.11%	18
2015 Q3	$398K	Hold	12,500	–	–	0.09%	21
2015 Q2	$413K	Hold	12,500	–	–	0.09%	20
2015 Q1	$515K	Hold	12,500	–	–	0.11%	20
2014 Q4	$509K	Hold	12,500	–	–	0.11%	19
2014 Q3	$458K	Hold	12,500	–	–	0.11%	20
2014 Q2	$579K	Hold	12,500	–	–	0.13%	20
2014 Q1	$514K	Hold	12,500	–	–	0.13%	20
2013 Q4	$477K	Hold	12,500	–	–	0.11%	20
2013 Q3	$299K	Hold	12,500	–	–	0.08%	20
2013 Q2	$213K	Buy	+12,500	New	+$180K	0.06%	19

Other funds holding ANIK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Oaktop Capital Management II's ANIK Position: Q1 2021 in Review

Oaktop Capital Management II sold out of Anika Therapeutics (ANIK) in Q1 2021, closing a stake of 12,500 shares — an estimated $566K sold.

Oaktop Capital Management II first reported a position in ANIK in Q2 2013 and held it in 31 quarters. The position peaked at $725K in Q3 2017. 146 funds tracked by Wall St. Rank hold ANIK as of Q1 2021.

Oaktop Capital Management II reported no remaining Anika Therapeutics position as of Q1 2021 after selling out during the quarter.
Oaktop Capital Management II sold 12,500 Anika Therapeutics shares in Q1 2021, an estimated $566K.
Oaktop Capital Management II first reported a position in Anika Therapeutics in Q2 2013 and held it in 31 quarters.
Oaktop Capital Management II's Anika Therapeutics position peaked at $725K in Q3 2017.
146 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2021.

Based on Oaktop Capital Management II's 13F filing for Q1 2021, filed 17 May 2021.